Active Ingredients
ANTIMONIUM SULPHURATUM AUREUM 8X
BRYONIA 3X
DROSERA 4X
EUCALYPTUS GLOBULUS 3X
IPECACUANHA 3X
SPONGIA TOSTA 3X
ZINCUM GLUCONICUM 1X
Inactive Ingredients
Ethyl Alcohol
Fructose
Glycerin
Purified Water
ANTIMONIUM SULPHURATUM AUREUM 8X
BRYONIA 3X
DROSERA 4X
EUCALYPTUS GLOBULUS 3X
IPECACUANHA 3X
SPONGIA TOSTA 3X
ZINCUM GLUCONICUM 1X
Ethyl Alcohol
Fructose
Glycerin
Purified Water
Shake well before use.
Adults and children 12 years and older: Take 1-2 teaspoons (tsp) (5-10 mL) every 4 to 6 hours.
Do not exceed 12 teaspoons in a 24 hour period.
Children under 12 years of age: Consult a doctor.
Temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold.
Helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes.
Temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold.
Helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes.
Do not use this product fore persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or where coughis accompanied by excessive phlegm (mucus).
Ask a doctor before use if you have a persistent or chronic cough that lasts, is chronic as occurs with smoking, asthma, chronic bronchitis or emphysema or is accompanied by excessive phlegn (mucus).
Stop use and ask a doctor if new symptoms occur, symptoms worsen or do not get better within 7 days, if cough is accompanied by a fever, rash, or persistent headache.
These could be signs of a serious condition.
If pregnant or breast-feeding, ask a healthcare professional before use.
Keep out of reach of children.
In case of overdose, seek medical help or contact Posion Control Center immeditely.
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ANTIMONY PENTASULFIDE | ACTIVE INGREDIENT | 1433F1I86N | 1 | |
| BRYONIA ALBA ROOT | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| DROSERA ROTUNDIFOLIA | ACTIVE INGREDIENT | 75O014T1HG | 1 | |
| EUCALYPTUS GLOBULUS LEAF | ACTIVE INGREDIENT | S546YLW6E6 | 1 | |
| IPECAC | ACTIVE INGREDIENT | 62I3C8233L | 1 | |
| SPONGIA OFFICINALIS SKELETON, ROASTED | ACTIVE INGREDIENT | 1PIP394IID | 1 | |
| ZINC GLUCONATE | ACTIVE INGREDIENT | U6WSN5SQ1Z | 1 | |
| ANTIMONY | ACTIVE MOIETY | 9IT35J3UV3 | 1 | |
| BRYONIA ALBA ROOT | ACTIVE MOIETY | T7J046YI2B | 1 | |
| DROSERA ROTUNDIFOLIA | ACTIVE MOIETY | 75O014T1HG | 1 | |
| EUCALYPTUS GLOBULUS LEAF | ACTIVE MOIETY | S546YLW6E6 | 1 | |
| IPECAC | ACTIVE MOIETY | 62I3C8233L | 1 | |
| SPONGIA OFFICINALIS SKELETON, ROASTED | ACTIVE MOIETY | 1PIP394IID | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| FRUCTOSE | INACTIVE INGREDIENT | 6YSS42VSEV | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 53499-0193 | 53499-0193-9, 53499-0193-5 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANTIMONY PENTASULFIDE | 1433F1I86N | ACTIB |
| BRYONIA ALBA ROOT | T7J046YI2B | ACTIB |
| DROSERA ROTUNDIFOLIA FLOWERING TOP | 75O014T1HG | ACTIB |
| EUCALYPTUS GLOBULUS LEAF | S546YLW6E6 | ACTIB |
| IPECAC | 62I3C8233L | ACTIB |
| SPONGIA OFFICINALIS SKELETON, ROASTED | 1PIP394IID | ACTIB |
| ZINC GLUCONATE | U6WSN5SQ1Z | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| FRUCTOSE | 6YSS42VSEV | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 72 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SYRUP / ORAL | 1732.5 mg/5ml | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SOLUTION / RECTAL | 0.67 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION / ORAL | 20 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 205 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SUSPENSION / ORAL | 6000 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | TABLET / ORAL | 64.92 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f542d6c4-d43d-4010-a319-7c86e4b2d518 | 10ba549e-c532-4375-860f-5c499ea59479 | 2022-08-01 | Warnings | f542d6c4-d43d-4010-a319-7c86e4b2d518 10ba549e-c532-4375-860f-5c499ea59479 |
Adverse event summaries are temporarily unavailable. Other product information remains available.